Gene · 771
Papers1,772
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 1,772
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| CancerTrace: Multi-stage single-cell analysis of networked cancer evolution for driver and modulator gene identification. | Comput Struct Biotechnol J | 2025 | 41322005 | PubTator, text mining | PubMed |
| MultiGATE: integrative analysis and regulatory inference in spatial multi-omics data via graph representation learning. | Nat Commun | 2025 | 41136370 | PubTator, text mining | PubMed |
| Zinc-Facilitated Enzyme Disruption: Thiazolidinediones as Potent Carbonic Anhydrase Inhibitors in Hypoxic Cancer Microenvironments. | Curr Cancer Drug Targets | 2025 | 41088948 | PubTator, text mining | PubMed |
| Distinct Immune Landscape and Gene Expression Profiles in Breast Cancer: Young versus Non-Young Patients. | Breast Care (Basel) | 2025 | 41063765 | PubTator, text mining | PubMed |
| Manganese (III) tetrakis (4-benzoic acid) porphyrin (MnTBAP) represses sulfide:quinone oxidoreductase expression and targets the sulfido-redox system in glioblastoma models. | Redox Rep | 2025 | 40968499 | PubTator, text mining | PubMed |
| A Machine Learning-Based Hypoxia-Related Gene Signatures to Facilitate Prediction of Cetuximab Response in Patients with Colorectal Cancer. | Int J Med Sci | 2025 | 40959565 | PubTator, text mining | PubMed |
| Design and Synthesis of New Multi-Target Coumarin Analogues Acting as Carbonic Anhydrases IX/XII and Topoisomerase II Inhibitors With Apoptotic Potential. | Arch Pharm (Weinheim) | 2025 | 40931549 | PubTator, text mining | PubMed |
| Prediction of cellular morphology changes under perturbations with a transcriptome-guided diffusion model. | Nat Commun | 2025 | 40897731 | PubTator, text mining | PubMed |
| Bladder Cancer: Role of Circular RNAs in Oncogenesis, Tumor Suppression, and Therapeutic Target Identification. | Cancer Genomics Proteomics | 2025 | 40883021 | PubTator, text mining | PubMed |
| Intracellular IL1α in Peritumoral Monocytes Induces IL8 Production and Inhibits Mitophagy to Promote Stemness and Metastasis of Hepatocellular Carcinoma. | Cancer Res | 2025 | 40857615 | PubTator, text mining | PubMed |
| Network toxicology reveals glyphosate mechanisms in kidney injury and cancer. | Sci Rep | 2025 | 40851020 | PubTator, text mining | PubMed |
| Di-meta-Substituted Fluorinated Benzenesulfonamides as Potent and Selective Anticancer Inhibitors of Carbonic Anhydrase IX and XII. | J Med Chem | 2025 | 40833423 | PubTator, text mining | PubMed |
| Integration of multi-omics quantitative trait loci evidence reveals novel susceptibility genes for Alzheimer's disease. | Sci Rep | 2025 | 40820167 | PubTator, text mining | PubMed |
| Ligand-Based Pharmacophore Modeling and Quantum Computational Approaches for the Development of hCA XII Inhibitor. | IEEE Trans Comput Biol Bioinform | 2025 | 40811382 | PubTator, text mining | PubMed |
| Beyond the leaderboard: leveraging predictive modeling for protein-ligand insights and discovery. | Bioinformatics | 2025 | 40794688 | PubTator, text mining | PubMed |
| Retraction Note: Tiliroside as a CAXII inhibitor suppresses liver cancer development and modulates E2Fs/Caspase-3 axis. | Sci Rep | 2025 | 40730839 | PubTator, text mining | PubMed |
| A case report on pseudohypoaldosteronism with a pathogenic mutation of CA12 causes autosomal recessive isolated hyperchlorhidrosis disorder. | J Family Med Prim Care | 2025 | 40726654 | PubTator, text mining | PubMed |
| Identification of key targets and exploration of therapeutic molecular mechanisms of natural compound tangeretin in osteosarcoma. | Discov Oncol | 2025 | 40705154 | PubTator, text mining | PubMed |
| Systematic elucidation of the effective constituents and potential mechanisms of Scrophulariae Radix against neoplasm based on LC-MS, network pharmacology, and molecular docking approaches. | Front Plant Sci | 2025 | 40678554 | PubTator, text mining | PubMed |
| The reducing effect of TNF-α on carbonic anhydrase III gene expression in colon carcinoma and osteosarcoma cells. | Cytotechnology | 2025 | 40677738 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/771/papers?page=3